Profile
Northpond Ventures is a venture capital firm based in Bethesda, Maryland, founded in 2018. The firm is known for its focus on science-driven investments, particularly in the life sciences and digital health sectors. With a team of around 20 professionals, including five partners, Northpond Ventures is deeply engaged in the academic ecosystem, collaborating with institutions like Harvard and MIT to advance life science and engineering innovation.
The firm primarily invests in Series A rounds, targeting startups in the United States. Northpond Ventures has a diverse portfolio across life sciences, health tech, and high-tech sectors. It manages multiple funds, including the Northpond Foundry Fund I, and is actively seeking new investment opportunities. The firm is a member of the National Venture Capital Association and has co-invested with notable partners like Alexandria.
Notable investments by Northpond Ventures include companies such as 908 Devices - analytical devices, Vizgen - spatial genomics, CAMP4 Therapeutics - RNA therapies, DNAnexus - cloud-based genome informatics, and Current Health - remote patient monitoring. These investments highlight the firm's commitment to supporting breakthrough science and technology-driven businesses.
Industry
Northpond Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Northpond Foundry Fund I
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
—
|
August 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.